Literature DB >> 24610881

Kinetic evaluation study on the bioactivity of silver doped hydroxyapatite-polyvinyl alcohol nanocomposites.

Amany A Mostafa1, Hassane Oudadesse, Mayyada M H El Sayed, Gehan Kamal, Mohamed Kamel, Enas Foad.   

Abstract

This work investigates the effect of adding silver nanoparticles (NPs) in ppm on the bioactivity of hydroxyapatite/polyvinyl alcohol nanocomposites (HAV). HAV prepared by an in situ biomimetic approach was doped with different concentrations of silver NPs (HAV-Ag), and the formed powder samples were characterized by different techniques such as Inductively Coupled Plasma-Optical Emission Spectroscopy (ICP-EOS), X-ray diffraction, transmission electron microscope, and Fourier Transform Infrared Spectroscopy. Bioactivity was evaluated in simulated body fluid through studying the kinetics of Ca and P uptake onto the different HAV-Ag nanocomposites. Uptake profiles of Ca and P were well described by a pseudo-second order kinetic model, and the obtained kinetic parameters confirmed that the highest uptake capacities were achieved by adding less than 0.001 ppm of silver NPs which is an amount not detectable by ICP. Furthermore, HAV-Ag nanocomposites were shown to be non-toxic as well as have a strong antibacterial effect. Silver NPs significantly enhanced the bioactivity of HAV nanocomposites and thus the developed nanocomposites promise to be excellent biomaterials for bone and reconstructive surgery applications.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  antibacterial; bioactivity; hydroxyapatite nanocomposite; kinetics; silver nanoparticles

Mesh:

Substances:

Year:  2014        PMID: 24610881     DOI: 10.1002/jbm.a.35144

Source DB:  PubMed          Journal:  J Biomed Mater Res A        ISSN: 1549-3296            Impact factor:   4.396


  1 in total

1.  Bioactive glass doped with noble metal nanoparticles for bone regeneration: in vitro kinetics and proliferative impact on human bone cell line.

Authors:  Amany A Mostafa; Mayyada M H El-Sayed; Ahmed N Emam; Ahmed A Abd-Rabou; Reham M Dawood; Hassane Oudadesse
Journal:  RSC Adv       Date:  2021-07-25       Impact factor: 4.036

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.